Najib Shah, Sonal Desai & Dr. M. Mathisekaran Retire As Independent Directors Of CARE Ratings
Najib Shah, Sonal Desai, and Dr. M. Mathisekaran ceased to be Independent Directors of CARE Ratings Limited upon completion of their terms with effect from July 10, 2025.
Chris Griffith Steps Down As CEO Of Vedanta’s Base Metals Unit
Chris Griffith, Chief Executive Officer (CEO) of Vedanta Resources’ base metals unit, has resigned, according to people familiar with the matter.
Zee Shareholders Reject Promoters’ Stake Hike Proposal
Zee Entertainment Enterprises Limited was unable to secure shareholder approval for its plan to issue fully convertible warrants to promoter entities on a preferential basis.
Pranoy Roy Joins SAIL Board As Independent Director
Steel Authority of India Limited (SAIL) has appointed Pranoy Roy as an Independent Director, effective July 8, 2025.
Ashutosh Vaidya & Sonu Bhasin Reappointed As Public Interest Directors At Multi Commodity Exchange Of India
Ashutosh Vaidya and Sonu Bhasin have been reappointed as Public Interest Directors of Multi Commodity Exchange of India Limited, effective September 17, 2025.
Prithavi Raj Jindal & Tripti Jindal Arya Appointed As Joint MD & Director, Respectively, Of Jindal Saw
Prithavi Raj Jindal and Tripti Jindal Arya, who retired by rotation and were reappointed at the Annual General Meeting, have been appointed as Joint Managing Director and Director, respectively, of Jindal Saw Limited.
Linda Yaccarino Resigns As CEO Of X
Linda Yaccarino stepped down from her role as Chief Executive Officer (CEO) of X and shared her decision on the platform.
Venkatraman Venkateswaran Appointed As Executive Director Of The Federal Bank
Venkatraman Venkateswaran has been appointed as Executive Director of The Federal Bank Limited w.e.f. July 10, 2025, subject to approval of shareholders at the ensuing Annual General Meeting (AGM).
GlaxoSmithKline Pharmaceuticals Appoints Vishwanath Swarup As Commercial Head Of General Medicines
Vishwanath Swarup has been appointed as Commercial Head of General Medicines at GlaxoSmithKline Pharmaceuticals Limited, effective July 9, 2025.
MCA Introduces New CSR-1 Form To Enhance Compliance & Oversight
The Ministry of Corporate Affairs (MCA) has notified a revised CSR-1 form for the registration of entities implementing corporate social responsibility (CSR) initiatives on behalf of companies.
